Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Insulin Resistance × Cholecalciferol × Clear all

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 18 Vitamin D Deficiency 16 Prostatic Neoplasms 12 Polycystic Ovary Syndrome 8 Neoplasms 8 Colonic Neoplasms 8 Rectal Neoplasms 6 Myelodysplastic Syndromes 5 Colorectal Neoplasms 5 Osteoporosis 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Cardiovascular Diseases 4 Warts 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Leukemia, Myeloid, Acute 3 Leukemia 3 Brain Neoplasms 3 Adenomatous Polyps 3 Pathologic Processes 2 Pain 2 Obesity 2 Myeloproliferative Disorders 2 Myelodysplastic-Myeloproliferative Diseases 2 Melanoma 2 Male Urogenital Diseases 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Carcinoma, Hepatocellular 2

Interventions

Metformin 26 Pioglitazone 7 Exercise 7 Inositol 5 Insulin 4 Acupuncture Therapy 4 Ethinyl Estradiol 3 salicylsalicylic acid 2 drospirenone and ethinyl estradiol combination 2 Water 2 Tablets 2 Surveys and Questionnaires 2 Sugars 2 Resistance Training 2 High-Intensity Interval Training 2 Folic Acid 2 Diet Therapy 2 Cyproterone Acetate 2 Caloric Restriction 2 ziprasidone 1 maltodextrin 1 lime 1 drospirenone 1 cinnulin PF 1 adrenosterone 1 World Health Organization oral rehydration solution 1 Waist-Hip Ratio 1 Waist Circumference 1 Vitamin D 1 Tirzepatide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02164552 2014-06-16

CEOR-04-08

King Abdulaziz University

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡